Lv4
610 积分 2024-12-26 加入
Evolution in PH Care: 3 Decades of Milestones
1天前
已关闭
Effect of riociguat on exercise following balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension in Japan (THERAPY-HYBRID-BPA): a multicentre, double-blind, randomised, controlled, phase 4 trial
23天前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS ‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
24天前
已完结
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
25天前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
25天前
已完结
Defining a cure for type 1 diabetes: a call to action
27天前
已关闭
GLP-1 receptor agonists
27天前
已完结
The pleiotropic effects of sotatercept
28天前
已完结
Overview of the major clinical trials investigating stem cells–based therapies for diabetes
28天前
已完结
Artificial intelligence for diabetes care: current and future prospects
1个月前
已完结
皖公网安备34019202002308
